Nu Skin Enterprises, Inc. (NUS) financial statements (2020 and earlier)

Company profile

Business Address 75 WEST CENTER ST
PROVO, UT 84601
State of Incorp. DE
Fiscal Year End December 31
SIC 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments327398438368304300547
Cash and cash equivalents320387426357289288525
Short-term investments7111211141222
Receivables56533331353669
Inventory, net of allowances, customer advances and progress billings283296253250265338340
Inventory283296253250265338340
Prepaid expense 64115955 
Deferred costs 749   
Derivative instruments and hedges, assets  0102 
Deposits current assets 1     
Prepaid expense and other current assets11
Other current assets 161413   
Other undisclosed current assets7222313043103152
Total current assets:7397997787147068351,118
Noncurrent Assets
Operating lease, right-of-use asset116
Property, plant and equipment448465465445455465396
Intangible assets, net (including goodwill), including:280287183143137188196
Goodwill197197115115112112112
Intangible assets, net (excluding goodwill)839068  7583
Other undisclosed intangible assets, net (including goodwill)   2825 
Other noncurrent assets155144165136165127 
Prepaid expense and other noncurrent assets111
Other undisclosed noncurrent assets   3542  
Total noncurrent assets:998895812760799780703
TOTAL ASSETS:1,7371,6941,5901,4741,5061,6141,821
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities343370370316340336709
Accounts payable39485041293583
Accrued liabilities304323319275311301626
Debt25697883688368
Deferred tax liabilities     0
Other undisclosed current liabilities      (0)
Total current liabilities:368440447399408418777
Noncurrent Liabilities
Long-term debt and lease obligation423361311334182165114
Long-term debt, excluding current maturities342361311334182165114
Operating lease, liability81
Liabilities, other than long-term debt100112127779112386
Deferred revenue and credits   7 
Asset retirement obligations     5 
Deferred tax liabilities, net    1614
Liability, pension and other postretirement and postemployment benefits     6
Other liabilities10011212777918972
Other undisclosed noncurrent liabilities     (34)(14)
Total noncurrent liabilities:523473438411273254186
Total liabilities:891913885810680672962
Stockholders' equity
Stockholders' equity attributable to parent846782705664826942859
Common stock0000000
Treasury stock, value(1,325)(1,327)(1,305)(1,250)(1,017)(863)(827)
Additional paid in capital557553466440420414397
Accumulated other comprehensive loss(95)(80)(66)(84)(71)(52)(46)
Retained earnings1,7081,6361,6091,5591,4941,4421,334
Total stockholders' equity:846782705664826942859
TOTAL LIABILITIES AND EQUITY:1,7371,6941,5901,4741,5061,6141,821

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues2,5202,6792,2792,2082,2472,4863,177
Revenue, net2,2792,2082,2472,4863,097
Cost of revenue
(Cost of Goods and Services Sold)
(603)(634)(502)(500)(490)(528)(506)
Other undisclosed gross profit     134 
Gross profit:1,9182,0451,7771,7071,7582,0912,671
Operating expenses(1,686)(1,804)(1,503)(1,476)(1,513)(1,739)(2,117)
Operating income:231241274231245352554
Nonoperating income (expense)(15)(21)(9)(18)(33)(54)3
Foreign currency transaction gain (loss), before tax(2)(16)3(9)(27)(54) 
Interest and debt expense (7)(22)(16)(8)(13)(3)
Other undisclosed income from continuing operations before equity method investments, income taxes    8133
Income from continuing operations before equity method investments, income taxes:216212243197212299557
Other undisclosed income from continuing operations before income taxes 72216   
Income from continuing operations before income taxes:216220266213212299557
Income tax expense(100)(98)(136)(70)(79)(109)(192)
Net income available to common stockholders, diluted:116122129143133189365

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income:116122129143133189365
Other comprehensive income (loss)(2)(2)8(2)(0)4 
Other undisclosed comprehensive loss     (198)(359)
Comprehensive income (loss):113120137141133(5)6
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(10)(11)10(10)(20)189365
Comprehensive income, net of tax, attributable to parent:103108147130113184370

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: